MedPath

Study to assess the accuracy of two continuous glucose monitors in relation to the microcirculatory function at the adult intensive care.

Completed
Conditions
continuous glucose monitoring (continue glucose monitoring)microcirculation (microcirculatie)intensive care unit (intensive care)cardiothoracic surgery (cardiothoracale chirurgie)
Registration Number
NL-OMON23067
Lead Sponsor
P.H.J. van der Voort, MD, PhDOnze Lieve Vrouwen GasthuisOosterpark 9, 1091 AC Amsterdam, the NetherlandsEmail: p.h.j.vandervoort@olvg.nl
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

1. Admission to the hospital for elective open cardiac surgery (coronaty artery bypass graftl mitral-, tricuspidal- and aortic valve surgery);

2. Age 18-85 years;

Exclusion Criteria

Abdominal abnormalities that inhibit sensor insertion.

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Difference in glucose values (mmol/l) measured by the two CGMs, Guardian RT and FreeStyle Navigator, compared to 'gold standard' blood glucose values measured by the Accu-Chek Compact Plus (mmol/l), expressed as mean absolute difference (MAD) of glucose values.
Secondary Outcome Measures
NameTimeMethod
1. Microcirculatory function expressed as % of perfused vessels as measured by OPS;<br /><br>2. Microcirculatory function expressed as microvascular flow index (MFI) as measured by OPS;<br /><br>3. Tissue oxygen saturation (StO2) expressed as ratio oxygenated haemoglobin to total haemoglobin as measured by near infrared spectroscopy (NIRS);<br /><br>4. Systemic oxygen saturation (SpO2) expressed as % as measured by pulse oximetry;<br /><br>5. APACHE II score;<br /> <br>6. SOFA score.<br>
© Copyright 2025. All Rights Reserved by MedPath